Clock.bio
PrivateLast Round
Seed
Oct 9, 2024
Total Funding Raised
$9.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Clock.bio operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Seed round in October 2024.
Clock.bio is a biotechnology company that develops regenerative therapies to address age-related diseases by decoding the genetic programs of cellular rejuvenation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clock.bio Comparables
Compare Clock.bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shift Bioscience | 90% | |
| Retro Biosciences | 76% | |
| Turn Biotechnologies | 75% |
For institutional investors. Book with your work email.
Clock.bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 9, 2024 | ||||
| Pre Seed | Aug 31, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Clock.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LocalGlobe | Seed |
| BlueYard Capital | Seed, Pre Seed |
| Meltwind Advisory | Seed |
| Onsight Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 51% MoM.
- Aug 27, 2025
Dr. Michael Boehler, formerly of BioNTech, joins as CBO.
For institutional investors. Book with your work email.
Clock.bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clock.bio's valuation, stock price, and market status.
Is Clock.bio a public or private company?
Clock.bio is a private company.
What is the current stock price of Clock.bio?
Clock.bio is a private company, so its shares have no public market price. Caplight tracks Clock.bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clock.bio worth (valuation)?
Valuation information for Clock.bio is not publicly available.
Can I buy Clock.bio stock?
Clock.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clock.bio's last funding round?
Clock.bio's most recent funding round was Seed on October 9, 2024.
Who are the main investors in Clock.bio?
Key investors in Clock.bio include LocalGlobe.
Will Clock.bio IPO soon?
No public IPO plans have been announced for Clock.bio.
How can I track Clock.bio secondary market activity?
Caplight tracks bids, offers, and trades in Clock.bio's shares on secondary markets.